Verified
The ankle swelling improved during the first couple of weeks. I urinated more in the morning, so that timing suited me better. My potassium test was repeated after the dose change.
15 Sept 2026
Active ingredient: Spironolactone
Aldactone
Quality products
24/7 Support
Fast delivery
Delivery
from 4 days
Aldactone is a spironolactone tablet for people with fluid retention, heart failure, hypertension, or selected hormone-related conditions. It helps the kidneys remove excess sodium and water while reducing potassium loss by blocking aldosterone.
Description
Aldactone is a tablet containing spironolactone, a potassium-sparing diuretic and aldosterone receptor antagonist. It is prescribed for fluid retention, heart failure, hypertension, primary hyperaldosteronism, and selected hormone-related skin conditions. The dose is stated on the pack — follow the leaflet. By blocking aldosterone, it helps remove excess sodium and water while limiting potassium loss.
Composition
Aldactone contains spironolactone as its active ingredient. The product is supplied as a tablet. Spironolactone belongs to two closely related classes: potassium-sparing diuretics and mineralocorticoid receptor antagonists.
Active Ingredient Profile
Spironolactone blocks the action of aldosterone, a hormone produced by the adrenal glands. Aldosterone normally signals the kidneys to retain sodium and water while excreting potassium. Blocking this signal changes how the distal renal tubules handle electrolytes and fluid.
Aldactone is also an aldosterone receptor antagonist. This distinction matters because its effects are hormonal as well as diuretic. Spironolactone can reduce aldosterone-driven fluid retention and also interfere with androgen activity in certain tissues.
The dose is stated on the pack — follow the leaflet. The correct amount and schedule depend on the condition being treated, kidney function, blood pressure, potassium level, and other medicines.
Take spironolactone at a consistent time each day. If it increases urination, a morning dose can reduce disruption during sleep, unless the prescriber has selected another schedule.
Dosage and usage
The tablet is taken by mouth at the dose selected for the diagnosed condition. The dose is stated on the pack — follow the leaflet. Prescribed regimens vary considerably between heart failure, oedema, hypertension, primary hyperaldosteronism, acne, and hirsutism.
Typical prescribing principles include:
- Take the tablet exactly at the prescribed frequency.
- Swallow it with water.
- Take it with food if advised, and keep the relationship with meals consistent.
- Take a missed dose when remembered unless the next scheduled dose is near.
- Skip a missed dose that is close to the next one.
- Do not double the next dose.
- Do not change the schedule because urine output seems lower or higher on one day.
For cardiovascular or fluid-related treatment, the prescriber may begin with a lower total daily amount and adjust it after checking blood pressure, renal function, and serum potassium. The dose is stated on the pack — follow the leaflet.
For acne, hirsutism, or hair-related treatment, the dose is selected according to age, reproductive status, blood pressure, kidney function, and concurrent medicines. Such use often requires a longer assessment period than treatment for acute fluid retention.
One practical issue is urination. The effect can be inconvenient if taken late in the evening, yet moving the dose without considering the full regimen can reduce adherence or affect blood pressure control.
Avoid taking a double dose after forgetting one. A delayed tablet followed by the full next dose can increase dizziness, low blood pressure, and potassium elevation.
How it works
Spironolactone competes with aldosterone at mineralocorticoid receptors in the distal renal tubules and collecting ducts. When aldosterone cannot activate these receptors, the kidneys reduce sodium reabsorption and retain more potassium. Water follows sodium, so urinary sodium and water excretion increase.
This mechanism explains why Aldactone is called a potassium-sparing diuretic. It can remove fluid without causing the same degree of potassium loss associated with some other diuretics. The trade-off is hyperkalaemia, especially when kidney function is reduced or other potassium-raising medicines are present.
Spironolactone is also an anti-androgen. It can reduce androgen production and limit androgen binding or activity in peripheral tissues. This action supports selected dermatological and endocrine uses, but it also explains possible breast tenderness, menstrual irregularity, reduced libido, and gynecomastia. These effects vary by indication. Clinical follow-up helps distinguish treatment benefit from adverse effects.
The FDA prescribing information describes spironolactone as a competitive antagonist of aldosterone at the mineralocorticoid receptor [1]. In practical terms, it interrupts an endocrine message that promotes salt retention.
Aldactone does not work like a rapid “water-loss” tablet for occasional use. Its effect develops through regulated changes in aldosterone signalling, so taking extra tablets to increase urination can create dangerous potassium changes.
Indications
Aldactone is used when aldosterone activity contributes to high blood pressure, fluid accumulation, or abnormal electrolyte balance. The medicine may be prescribed in cardiology, nephrology, endocrinology, hepatology, and dermatology.
Cardiovascular and Renal Applications
Clinical uses include:
- Heart failure with reduced ejection fraction, as part of a broader treatment plan
- Hypertension, especially when additional aldosterone blockade is useful
- Oedema associated with heart, liver, or kidney disease
- Ascites related to cirrhosis
- Primary hyperaldosteronism
- Potassium loss caused by selected diuretic regimens
- Fluid retention linked with nephrotic syndrome in selected cases
| Clinical use | Main therapeutic aim |
|---|---|
| Heart failure or oedema | Reduce aldosterone-related sodium and water retention |
| Hypertension | Lower circulating fluid volume and aldosterone effects |
| Primary hyperaldosteronism | Block excessive mineralocorticoid activity |
Primary hyperaldosteronism occurs when the body produces too much aldosterone. That excess can raise blood pressure and lower potassium. Spironolactone addresses the hormonal mechanism rather than simply increasing urine production.
In heart failure, treatment decisions are based on kidney function, potassium concentration, blood pressure, and the wider cardiovascular regimen. The medicine can improve fluid control, yet its potassium-retaining effect creates a need for laboratory monitoring.
Dermatological and Endocrine Applications
Spironolactone has anti-androgen effects. Dermatology specialists may prescribe it for acne, hirsutism, or androgen-related hair concerns in selected women. These uses are often outside the core cardiovascular indications and require attention to pregnancy risk, menstrual effects, breast tenderness, and potassium status.
Alopecia treatment is also specialist-led. The expected benefit depends on the cause of hair loss, the patient’s hormonal profile, and the length of treatment. Improvement is gradual rather than immediate.
The treatment goal differs by condition. A person using Aldactone for oedema may notice changes in fluid balance, while someone receiving spironolactone for acne may need several weeks or months before judging skin response.
Comparison
Alternative treatment depends on the therapeutic goal. Eplerenone is another mineralocorticoid receptor antagonist. It has greater receptor selectivity than spironolactone and may cause fewer sex-hormone-related effects, although hyperkalaemia and kidney-related precautions remain relevant.
Triamterene is a potassium-sparing diuretic with a different mechanism. It acts directly on epithelial sodium channels in the renal collecting duct rather than blocking the mineralocorticoid receptor. It may be used in selected diuretic combinations, yet it also carries a risk of hyperkalaemia.
| Medicine category | Main mechanism | Practical distinction |
|---|---|---|
| Spironolactone | Blocks mineralocorticoid receptors and has anti-androgen activity | Useful when aldosterone and androgen effects both matter |
| Eplerenone | More selective mineralocorticoid receptor blockade | Fewer hormone-related adverse effects for some patients |
| Triamterene | Directly reduces sodium entry through renal epithelial channels | Potassium-sparing without the same anti-androgen mechanism |
A clinician may favour eplerenone when breast tenderness or gynecomastia becomes problematic. Spironolactone may remain preferred when anti-androgen activity or extensive clinical experience is relevant. Triamterene is not a direct substitute for the hormonal effects of spironolactone.
The European Medicines Agency describes eplerenone within the mineralocorticoid receptor antagonist group, with kidney function and potassium monitoring central to safe use [3].
Contraindications
Aldactone is not appropriate for everyone. NOT for you if you have hyperkalaemia, anuria, or significant renal impairment unless a specialist has given specific direction. The medication is generally avoided or requires specialist direction in the following situations:
- Hyperkalaemia
- Significant renal impairment or rapidly worsening kidney function
- Anuria, meaning little or no urine production
- Addison’s disease or another state of inadequate adrenal hormone production
- Previous serious reaction to spironolactone
- Concurrent use of eplerenone or another mineralocorticoid receptor antagonist without a clear specialist plan
- Concomitant potassium supplementation when potassium is already high
- Pregnancy when used for acne, hirsutism, or other anti-androgen purposes
Pregnancy requires careful indication-specific assessment because anti-androgen activity may affect a developing male fetus. Breastfeeding decisions also depend on the dose, indication, and the infant’s circumstances.
When this is not for you
Aldactone may not be suitable if you have high potassium, serious or worsening kidney problems, or little or no urine production. It also needs medical review if you have Addison’s disease, have previously had a serious reaction to spironolactone, or are already taking another aldosterone-blocking medicine. Do not use it for acne, hirsutism, or other anti-androgen purposes during pregnancy without specialist advice.
Side effects
Aldactone can cause predictable diuretic, cardiovascular, renal, and hormonal adverse effects. The most important laboratory concern is hyperkalaemia, meaning an abnormally high potassium concentration.
Common or clinically relevant effects include:
- Increased urination
- Dizziness or light-headedness from lower blood pressure
- Nausea, abdominal discomfort, or diarrhoea
- Headache or fatigue
- Breast tenderness
- Menstrual irregularity
- Reduced libido
- Erectile difficulties
- Gynecomastia in some men
- Changes in kidney function
- Hyperkalaemia
Hyperkalaemia may cause muscle weakness, tingling, nausea, palpitations, or abnormal heart rhythms. It can also occur without obvious symptoms. Blood testing is therefore more reliable than judging potassium status by how a person feels.
Gynecomastia is a recognised endocrine effect. It may develop after continued exposure and can persist for some time after treatment changes. Reported risk varies with dose, duration, sex, age, and the underlying condition.
The FDA label identifies hyperkalaemia, renal impairment, hypotension, and endocrine effects among the important safety concerns associated with spironolactone [2]. Patients with vomiting, diarrhoea, dehydration, or a sudden reduction in urine output may need prompt clinical assessment because fluid and kidney changes can alter spironolactone exposure.
Do not use potassium-based salt substitutes casually while taking spironolactone. Some contain substantial potassium chloride and can raise potassium even when no potassium tablets are being used.
Common mistakes
Several practical errors can reduce benefit or increase harm:
- Taking extra tablets to produce more urine
- Stopping treatment when swelling improves without a planned review
- Taking the medicine at irregular times
- Using potassium supplements without checking the full medication list
- Treating potassium-rich salt substitutes as harmless seasoning
- Forgetting to mention ibuprofen, naproxen, or trimethoprim
- Assuming that normal urination means potassium is normal
- Judging acne or hair treatment after only a few days
- Moving the dose to bedtime without considering nocturnal urination
- Continuing treatment through severe vomiting, diarrhoea, or dehydration without medical advice
Another frequent mistake is confusing fluid weight with body-fat change. A reduction in swelling can change scale weight quickly, while anti-androgen treatment for acne or hirsutism usually requires a much longer evaluation.
Stopping suddenly may not produce withdrawal in the way some medicines do, yet the original condition can return. People using Aldactone for heart failure, hypertension, ascites, or primary hyperaldosteronism should not discontinue it casually.
What doctors say
In clinical practice, doctors usually judge Aldactone by more than symptom improvement. Blood pressure, body weight, swelling, breathlessness, kidney function, and serum potassium all help determine whether treatment is producing the intended effect.
A cardiologist may describe spironolactone as a treatment that targets aldosterone biology rather than simply increasing urine volume. A nephrologist will focus on filtration rate and potassium clearance. A dermatologist will weigh anti-androgen benefit against menstrual, breast, pregnancy, and electrolyte considerations.
The main limitation is predictable: the same potassium-sparing action that makes spironolactone useful can become hazardous when kidney clearance is poor. Patients who feel well can still develop hyperkalaemia, so clinical monitoring should not be replaced by symptom tracking.
The World Health Organization’s hypertension guidance and American Heart Association recommendations support structured blood-pressure treatment and medication review rather than isolated reliance on a single reading [4]. For heart failure, treatment is adjusted according to the patient’s broader cardiovascular plan, renal results, and tolerance.
Frequently asked questions
Is Aldactone a steroid?
Aldactone is not a corticosteroid. It contains spironolactone, a synthetic steroidal compound that acts as a mineralocorticoid receptor antagonist and has anti-androgen properties. The FDA prescribing information from 2023 identifies its principal pharmacological action as blockade of aldosterone activity. Its chemical steroid structure does not mean that it produces the same effects as anabolic steroids or corticosteroids.
What is Aldactone used for?
Aldactone is used for conditions involving aldosterone activity, fluid retention, or selected androgen-related problems. Common clinical indications include heart failure, oedema, hypertension, primary hyperaldosteronism, acne, and hirsutism. The FDA’s 2023 prescribing information supports its use in defined cardiovascular, oedema-related, and endocrine settings. Dermatological use requires a separate assessment of reproductive status, potassium risk, and treatment goals.
Does Aldactone lower potassium?
Aldactone usually reduces potassium excretion rather than lowering potassium. This potassium-sparing action can be useful when another diuretic has caused potassium loss, but it can also produce hyperkalaemia. The FDA safety information from 2023 emphasises kidney function, potassium monitoring, and interaction review. Potassium tablets and potassium-containing salt substitutes can increase the risk.
How long does Aldactone take to work?
The timing depends on the condition. Changes in urine output or swelling may appear earlier than improvements in acne, hirsutism, or hair-related concerns. NICE guidance from 2021 on heart failure places spironolactone within monitored long-term treatment rather than short-term symptom relief. A response should be judged using the relevant clinical measure, such as blood pressure, oedema, potassium, or skin findings.
Can Aldactone be taken with blood-pressure medicine?
It can be combined with some blood-pressure medicines, but the combination may increase low blood pressure, kidney problems, or hyperkalaemia. ACE inhibitors, angiotensin receptor blockers, and aliskiren require special attention when used with spironolactone. The European Medicines Agency’s 2022 mineralocorticoid antagonist information highlights potassium and renal monitoring as key safety measures. The complete medicine list should be reviewed whenever treatment is started or changed.
Does Aldactone cause weight gain?
Aldactone is generally used to reduce sodium-related fluid retention, so it does not usually cause weight gain through fat accumulation. Weight can fluctuate because of fluid shifts, appetite changes, reduced activity, or the underlying heart, liver, or kidney condition. The FDA information from 2023 treats changes in fluid status and adverse effects as clinically relevant monitoring points. A rapid increase in weight with worsening swelling or breathlessness needs prompt medical assessment.
Do you offer anonymous delivery?
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Comparison
Compare all medications for HypertensionAldactone: Reviews and Experiences
3.8
Based on 4 reviews
Verified
The first month brought breast tenderness and irregular bleeding. The skin improvement became easier to see later, but the early side effects were frustrating.
26 Sept 2026
Verified
Breathing and leg swelling were better after the treatment was adjusted. I felt light-headed on some mornings, and the dose had to be reviewed with my other blood-pressure tablets.
02 Oct 2026
Verified
The change was slow. I noticed less new growth after several months, but the menstrual changes meant that follow-up mattered.
13 Oct 2026
Sources
- U.S. Food and Drug Administration (2023). Aldactone (spironolactone) tablets: Prescribing Information.
- U.S. Food and Drug Administration (2019). Spironolactone tablets: Prescribing Information.
- European Medicines Agency (2022). Eplerenone: Summary of Product Characteristics.
- World Health Organization (2021). Guideline for the Pharmacological Treatment of Hypertension in Adults.
